Exo2
Product Specifications
Background
Exo2 disrupts the Golgi apparatus and stimulates Golgi-ER fusion in mammalian cells.1 May be used to completely ablate the Golgi apparatus.1 Like brefeldin A (BFA), it inhibits anterograde transport and disrupts morphology of the trans-Golgi network (TGN) but unlike BFA, it does not induce tubulation and merging of the TGN and endosomal compartments.2 It perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network, in contrast to cholera toxin.1,2 Accelerates degradation of perilipin-2 proteins.3
Conjugation
Unconjugated
Buffer
Yellow solid
Storage Conditions
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6287308-01 0.2 mL
CNOT8, NT (CNOT8, CALIF, POP2, CCR4-NOT transcription complex subunit 8, CAF1-like protein, CAF2, CCR4-associated factor 8) (Biotin)
Sign In for Pricing
View Details 
MBS6287308-02 5x 0.2 mL
CNOT8, NT (CNOT8, CALIF, POP2, CCR4-NOT transcription complex subunit 8, CAF1-like protein, CAF2, CCR4-associated factor 8) (Biotin)
Sign In for Pricing
View Details 
GTR15156454 1 Vial
Lentiviral human UBE4A shRNA (UAS) - Lentiviral human UBE4A shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details MBS6498519-01 0.2 mL
SCF, NT (Kit Ligand, C-kit Ligand, Stem Cell Factor, Mast Cell Growth Factor, MGF, KITLG) (APC)
Sign In for Pricing
View Details 
MBS6498519-02 5x 0.2 mL
SCF, NT (Kit Ligand, C-kit Ligand, Stem Cell Factor, Mast Cell Growth Factor, MGF, KITLG) (APC)
Sign In for Pricing
View Details